Edition:
United States

Meridian Bioscience Inc (VIVO.OQ)

VIVO.OQ on NASDAQ Stock Exchange Global Select Market

17.60USD
9:46am EST
Change (% chg)

$-0.20 (-1.12%)
Prev Close
$17.80
Open
$17.75
Day's High
$17.80
Day's Low
$17.60
Volume
19,173
Avg. Vol
73,104
52-wk High
$21.49
52-wk Low
$15.77

VIVO.OQ

Chart for VIVO.OQ

About

Meridian Bioscience, Inc. (Meridian) is an integrated life science company. The Company is engaged in developing, manufacturing, selling and distribution of clinical diagnostic test kits, for certain gastrointestinal, viral, respiratory and parasitic infectious diseases; the manufacture and distribution of bulk antigens,... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $749.53
Shares Outstanding(Mil.): 42.11
Dividend: 0.20
Yield (%): 4.49

Financials

  VIVO.OQ Industry Sector
P/E (TTM): 23.42 31.03 30.77
EPS (TTM): 0.76 -- --
ROI: 16.22 13.42 15.23
ROE: 19.39 17.11 16.56

BRIEF-Meridian Bioscience - Magellan Diagnostics receives CFDA clearance for Leadcare II in China

* Magellan Diagnostics receives CFDA clearance for Leadcare II in China Source text for Eikon: Further company coverage:

Aug 09 2016

BRIEF-Meridian Bioscience reports Q3 EPS of $0.21

* Meridian Bioscience reports third quarter 2016 operating results, declares regular cash dividend, and updates fiscal 2016 guidance

Jul 28 2016

BRIEF-Meridian Bioscience gets FDA clearance for test to detect mycoplasma pneumoniae

* Meridian Bioscience Inc receives FDA clearance for new molecular test for the detection of mycoplasma pneumoniae Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jun 15 2016

Competitors

Earnings vs. Estimates